NovaBay Pharmaceuticals
(NYSEMKT) NBY
NovaBay Pharmaceuticals Financials at a Glance
Market Cap
$33.08M
Revenue (TTM)
$0.00
Net Income (TTM)
$522.59M
EPS (TTM)
-$7.43
P/E Ratio
-0.16
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$1.22
Volume
131,888
Open
$1.18
Price
$1.22
Volume
131,888
Open
$1.18
Previous Close
$1.22
Daily Range
$1.18 - $1.25
52-Week Range
$1.01 - $99.75
Estimated Earnings Date
Apr 1, 2026
Dividend
$0.00
Beta (Volatility)
0.74 (Low)
Price
$1.22
Volume
131,888
Open
$1.18
Previous Close
$1.22
Daily Range
$1.18 - $1.25
52-Week Range
$1.01 - $99.75
Estimated Earnings Date
Apr 1, 2026
NBY News
Avoid This Drug Stock
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NovaBay Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
14
CEO
Michael Kazley
Website
www.novabay.comHeadquarters
EmeryVille, CA 94608, US
NBY Financials
Key Financial Metrics (TTM)
Gross Margin
-3%
Operating Margin
-2%
Net Income Margin
212%
Return on Equity
-588%
Return on Capital
-3%
Return on Assets
3%
Earnings Yield
-6.25%
Dividend Yield
0.00%
Payout Ratio
0.92%
Stock Overview
Market Cap
$33.08M
Shares Outstanding
27.12M
Volume
131.89K
Avg. Volume
317.08K
Financials (TTM)
Gross Profit
-$140.00K
Operating Income
-$7.59M
EBITDA
-$7.45M
Operating Cash Flow
-$8.43M
Capital Expenditure
$0.00
Free Cash Flow
-$8.43M
Cash & ST Invst.
$7.96M
Total Debt
$776.00K
NovaBay Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$33.08M
N/A
Market Cap/Employee
$2.54M
N/A
Employees
13
N/A
Net Income
$552.40M
+7102.1%
EBITDA
$3.00K
+100.1%
Quarterly Fundamentals
Total Cash
$18.41M
+117.4%
Total Debt
$637.00K
-43.4%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$166.00K
-74.0%
Short Term Debt
$471.00K
-3.3%
Return on Assets
2.91%
N/A
Return on Invested Capital
-2.99%
N/A
Free Cash Flow
-$1.80M
-36.3%
Operating Cash Flow
-$1.80M
-36.3%